AAAAAA
Results: 1-25/63
Authors:
MANDLER R
LEVITZKI A
ROETTINGER AJ
GAZIT A
RAKHLIN YY
WALDMANN TA
Citation: R. Mandler et al., THE TYRPHOSTIN AG494 REDUCES IL2-INDUCED ACTIVATION OF JAK3 AND INHIBITS PROLIFERATION OF HUMAN LEUKEMIA-CELLS, European cytokine network, 9(3), 1998, pp. 505-505
Authors:
KLEIN S
REUVENI H
LEVITZKI A
Citation: S. Klein et al., SIGNAL-TRANSDUCTION BY A NON-DISSOCIABLE HETEROTRIMERIC YEAST G-PROTEIN, Molecular biology of the cell, 9, 1998, pp. 2101-2101
Authors:
WALKER F
KATO A
GONEZ LJ
HIBBS ML
POULIOT N
LEVITZKI A
BURGESS AW
Citation: F. Walker et al., ACTIVATION OF THE RAS MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY BY KINASE-DEFECTIVE EPIDERMAL GROWTH-FACTOR RECEPTORS RESULTS IN CELL-SURVIVAL BUT NOT PROLIFERATION/, Molecular and cellular biology (Print), 18(12), 1998, pp. 7192-7204
Authors:
CARLOSTELLA C
SAVOLDO B
SAMMARELLI G
REGAZZI E
GARAU D
MANGONI L
GAZIT A
LEVITZKI A
RIZZOLI V
Citation: C. Carlostella et al., EFFECT OF THE BCR-ABL-SPECIFIC INHIBITOR AG957 ON CHRONIC MYELOGENOUSLEUKEMIA PROGENITOR CELLS, Bone marrow transplantation, 21, 1998, pp. 298-298
Authors:
NAGANE M
LEVITZKI A
GAZIT A
CAVENEE WK
HUANG HJS
Citation: M. Nagane et al., DRUG-RESISTANCE OF HUMAN GLIOBLASTOMA CELLS CONFERRED BY A TUMOR-SPECIFIC MUTANT EPIDERMAL GROWTH-FACTOR RECEPTOR THROUGH MODULATION OF BCL-X-L AND CASPASE-3-LIKE PROTEASES, Proceedings of the National Academy of Sciences of the United Statesof America, 95(10), 1998, pp. 5724-5729
Authors:
LIPSON KE
PANG L
HUBER LJ
CHEN H
TSAI JM
HIRTH P
GAZIT A
LEVITZKI A
MCMAHON G
Citation: Ke. Lipson et al., INHIBITION OF PLATELET-DERIVED GROWTH-FACTOR AND EPIDERMAL GROWTH-FACTOR RECEPTOR SIGNALING EVENTS AFTER TREATMENT OF CELLS WITH SPECIFIC SYNTHETIC INHIBITORS OF TYROSINE KINASE PHOSPHORYLATION, The Journal of pharmacology and experimental therapeutics, 285(2), 1998, pp. 844-852
Authors:
BRENNER T
PORADOSU E
SOFFER D
SICSIC C
GASIT A
LEVITZKI A
Citation: T. Brenner et al., SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY TYRPHOSTIN AG-556, Journal of neurochemistry, 70, 1998, pp. 47-47
Authors:
KLEINBERGERDORON N
SHELAH N
CAPONE R
GAZIT A
LEVITZKI A
Citation: N. Kleinbergerdoron et al., INHIBITION OF CDK2 ACTIVATION BY SELECTED TYRPHOSTINS CAUSES CELL-CYCLE ARREST AT LATE G1 AND S-PHASE, Experimental cell research, 241(2), 1998, pp. 340-351
Authors:
BANAI S
WOLF Y
GOLOMB G
PEARLE A
WALTENBERGER J
FISHBEIN I
SCHNEIDER A
GAZIT A
PEREZ L
HUBER R
LAZAROVICHI G
RABINOVICH L
LEVITZKI A
GERTZ SD
Citation: S. Banai et al., PDGF-RECEPTOR TYROSINE KINASE BLOCKER AG1295 SELECTIVELY ATTENUATES SMOOTH-MUSCLE CELL-GROWTH IN-VITRO AND REDUCES NEOINTIMAL FORMATION AFTER BALLOON ANGIOPLASTY IN SWINE, Circulation, 97(19), 1998, pp. 1960-1969
Authors:
LEVITZKI A
Citation: A. Levitzki, TARGETING SIGNAL-TRANSDUCTION FOR DISEASE THERAPY, Medical oncology, 14(2), 1997, pp. 83-89
Authors:
WESSELY O
MELLITZER G
VONLINDERN M
LEVITZKI A
GAZIT A
ISCHENKO I
HAYMAN MJ
BEUG H
Citation: O. Wessely et al., DISTINCT ROLES OF THE RECEPTOR TYROSINE KINASES C-ERBB AND C-KIT IN REGULATING THE BALANCE BETWEEN ERYTHROID CELL-PROLIFERATION AND DIFFERENTIATION, Cell growth & differentiation, 8(5), 1997, pp. 481-493
Authors:
CARLOSTELLA C
REGAZZI E
GARAU D
SAVOLDO B
SAMMARELLI G
RIZZO MT
LEVITZKI A
RIZZOLI V
Citation: C. Carlostella et al., EFFECT OF AG957, A BCR-ABL-SPECIFIC TYROSINE KINASE INHIBITOR, ON CHRONIC MYELOGENOUS LEUKEMIA PROGENITOR CELLS, Experimental hematology, 25(8), 1997, pp. 188-188
Authors:
CILLONI D
LEVITZKI A
REGAZZI E
GARAU D
SAVOLDO B
SAMMARELLI G
ALMICI C
RIZZOLI V
CARLOSTELLA C
Citation: D. Cilloni et al., AMIFOSTINE PRETREATMENT ALLOWS THE USE OF HIGHER DOSES OF THE BCR-ABL-SPECIFIC TYROSINE KINASE INHIBITOR AG1112, Experimental hematology, 25(8), 1997, pp. 376-376
Authors:
LEVITZKI A
Citation: A. Levitzki, TARGETING SIGNAL-TRANSDUCTION PATHWAYS FOR DISEASE THERAPY, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 63-63
Authors:
SEVRANSKY JE
SHAKED G
NOVOGRODSKY A
LEVITZKI A
GAZIT A
HOFFMAN A
ELIN RJ
QUEZADO ZMN
FREEMAN BD
EICHACKER PQ
DANNER RL
BANKS SM
BACHER J
THOMAS ML
NATANSON C
Citation: Je. Sevransky et al., TYRPHOSTIN AG-556 IMPROVES SURVIVAL AND REDUCES MULTIORGAN FAILURE INCANINE ESCHERICHIA-COLI PERITONITIS, The Journal of clinical investigation, 99(8), 1997, pp. 1966-1973
Authors:
LOPEZTALAVERA JC
LEVITZKI A
MARTINEZ M
GAZIT A
ESTEBAN R
GUARDIA J
Citation: Jc. Lopeztalavera et al., TYROSINE KINASE INHIBITION AMELIORATES THE HYPERDYNAMIC STATE AND DECREASES NITRIC-OXIDE PRODUCTION IN CIRRHOTIC RATS WITH PORTAL-HYPERTENSION AND ASCITES, The Journal of clinical investigation, 100(3), 1997, pp. 664-670
Authors:
OSHEROV N
LEVITZKI A
Citation: N. Osherov et A. Levitzki, TYRPHOSTIN AG-494 BLOCKS CDK2 ACTIVATION, FEBS letters, 410(2-3), 1997, pp. 187-190
Authors:
PARRIZAS M
GAZIT A
LEVITZKI A
WERTHEIMER E
LEROITH D
Citation: M. Parrizas et al., SPECIFIC-INHIBITION OF INSULIN-LIKE GROWTH-FACTOR-I AND INSULIN-RECEPTOR TYROSINE KINASE-ACTIVITY AND BIOLOGICAL FUNCTION BY TYRPHOSTINS, Endocrinology, 138(4), 1997, pp. 1427-1433
Authors:
LEVITZKI A
BENYEHUDA D
Citation: A. Levitzki et D. Benyehuda, THE TYRPHOSTIN AG17 INDUCES APOPTOSIS AND INHIBITION OF CDK2 ACTIVITYIN A LYMPHOMA CELL-LINE THAT OVEREXPRESSES BCL-2 - REPLY, Cancer research, 57(24), 1997, pp. 5610-5610
Authors:
BENBASSAT H
ROSENBAUMMITRANI S
HARTZSTARK Z
SHLOMAI Z
KLEINBERGERDORON N
GAZIT A
PLOWMAN G
LEVITZKI R
TSVIELI R
LEVITZKI A
Citation: H. Benbassat et al., INHIBITORS OF EPIDERMAL GROWTH-FACTOR RECEPTOR KINASE AND OF CYCLIN-DEPENDENT KINASE-2 ACTIVATION INDUCE GROWTH ARREST, DIFFERENTIATION, AND APOPTOSIS OF HUMAN PAPILLOMA-VIRUS 16-IMMORTALIZED HUMAN KERATINOCYTES, Cancer research, 57(17), 1997, pp. 3741-3750
Authors:
PALUMBO GA
YAROM N
GAZIT A
SANDALON Z
BANIYASH M
KLEINBERGERDORON N
LEVITZKI A
BENYEHUDA D
Citation: Ga. Palumbo et al., THE TYRPHOSTIN AG17 INDUCES APOPTOSIS AND INHIBITION OF CDK2 ACTIVITYIN A LYMPHOMA CELL-LINE THAT OVEREXPRESSES BCL-2, Cancer research, 57(12), 1997, pp. 2434-2439
Authors:
CARLOSTELLA C
SAVOLDO B
SAMMARELLI G
REGAZZI E
GARAU D
ALMICI C
MANGONI L
GAZIT A
LEVITZKI A
RIZZOLI V
Citation: C. Carlostella et al., EFFECT OF THE BCR-ABL-SPECIFIC INHIBITOR AG957 ON CHRONIC MYELOGENOUSLEUKEMIA PROGENITOR CELLS, Blood, 90(10), 1997, pp. 350-350
Authors:
KOVALENKO M
RONNSTRAND L
HELDIN CH
LOUBTCHENKOV M
GAZIT A
LEVITZKI A
BOHMER FD
Citation: M. Kovalenko et al., PHOSPHORYLATION SITE-SPECIFIC INHIBITION OF PLATELET-DERIVED GROWTH-FACTOR BETA-RECEPTOR AUTOPHOSPHORYLATION BY THE RECEPTOR BLOCKING TYRPHOSTIN AG1296, Biochemistry, 36(21), 1997, pp. 6260-6269
Authors:
LEVITZKI A
Citation: A. Levitzki, TARGETING SIGNAL-TRANSDUCTION FOR DISEASE THERAPY, Current opinion in cell biology, 8(2), 1996, pp. 239-244
Authors:
LOPEZTALAVERA JC
LEVITZKI A
MARTINEZ M
ESTEBAN R
GUARDIA J
Citation: Jc. Lopeztalavera et al., TYROSINE KINASE INHIBITION AMELIORATES THE HYPERDYNAMIC STATE AND DECREASES NITRIC-OXIDE PRODUCTION IN CIRRHOTIC RATS WITH PORTAL-HYPERTENSION AND ASCITES, Hepatology, 24(4), 1996, pp. 755-755